Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

NCT00432562

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Clinical Investigative Site Buenos Aires, Argentina
  • Clinical Investigative Site Mendoza, Argentina
  • Clinical Investigative Site Rosario, Argentina
  • Clinical Investigative Site San Miguel de Tucumán, Argentina
View Trial Details
Completed

A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00138658

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • LAC-USC Medical Center Los Angeles, California, United States
  • University of Southern California Norris Los Angeles, California, United States
  • New York Oncology Hematology Albany, New York, United States
  • Oregon Health and Science University Portland, Oregon, United States
View all 15 locations
View Trial Details
Completed

Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer

NCT00408226

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Iowa City, Iowa, United States
  • Swedish Cancer Institute Seattle, Washington, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Molecular Profiling in Lung Cancer Patients

NCT00191308

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra, Poland
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland
View Trial Details
Completed

A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

NCT00085826

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham Hematology Oncology Associates Birmingham, Alabama, United States
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • Northern Arizona Hematology and Oncology Associates Flagstaff, Arizona, United States
  • Hematology & Oncology Associates Phoenix, Arizona, United States
View all 114 locations
View Trial Details

Related conditions